XML 36 R26.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2017

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

The financial information of Biox, which was included in the accompanying consolidated financial statements, is presented as follows:

	(in thousands)
	As of December 31, 2017		As of December 31, 2016

Cash and cash equivalents	$	41	$	13
Total assets	$	1,599	$	1,451
Total liabilities	$	1,745	$	1,133

	(in thousands)
	Year ended December 31,
	2017			2016

Total net revenue	$	1,597		$	1,850

Net (loss) income	$	(524	)	$	185

Changes in Allowance for Doubtful Accounts and Commission Adjustments

The changes in the Company’s allowance for doubtful accounts and commission adjustments are as follows:

	(in thousands)
	For the year ended December 31, 2017			For the year ended December 31, 2016
Beginning Balance	$	4,159		$	3,863
Provision for losses on accounts receivable		157			140
Direct write-offs, net of recoveries		(212	)		(85	)
Commission adjustments		768			241
Ending Balance	$	4,872		$	4,159

Reconciliation of Basic to Diluted Shares Used in Earnings Per Share Calculation

A reconciliation of basic to diluted shares used in the earnings per share calculation is as follows:

	(in thousands)
	For the year ended
	December 31, 2017		December 31, 2016

Basic weighted average shares outstanding		162,213		159,138
Dilutive effect of options and unvested restricted shares		-		258
Diluted weighted average shares outstanding		162,213		159,396

Common Stock Equivalents Excluded from Computation of Diluted Earnings Per Share

The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the years ended December 31, 2017 and 2016, because the effect of their inclusion would be anti-dilutive.

	(in thousands)
	For the year ended
	December 31, 2017		December 31, 2016

Restricted common stock grants		4,204		2,763

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details